Skip to main content

Treatment of Acute Leukemias

New Directions for Clinical Research

  • Book
  • © 2003

Overview

Part of the book series: Current Clinical Oncology (CCO)

  • 6854 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (42 chapters)

  1. Diagnosis, Classification, and Prognosis

  2. Chemotherapeutic Strategies

    1. Infant Leukemias

    2. Childhood Acute Lymphoblastic Leukemia

    3. Acute Lymphoblastic Leukemia in Adolescents and Young Adults

    4. Acute Lymphoblastic Leukemia in Adults

    5. Central Nervous System Therapy for Acute Lymphoblastic Leukemia

    6. Relapsed Acute Lymphoblastic Leukemia

    7. B-Cell Acute Lymphoblastic Leukemia

    8. Acute Myeloid Leukemia in Children

Keywords

About this book

Although much progress has been made in the treatment of acute leukemia, there is still vigorous debate over the optimal methods for securing additional gains in event-free survival and for reducing the toxic side effects of "curative" therapy. In Treatment of Acute Leukemias: New Directions for Clinical Research, international experts not only review the state-of-the-art in managing children and adults with acute leukemia, but also debate the pros and cons of current controversial and problematic issues. The book summarizes the best diagnostic and treatment practices for newly diagnosed and relapsed acute lymphoblastic and myeloid leukemia in children, adolescents, and adults. Among the therapies considered are methotrexate, asparaginase, antipurines, epipodophyllotoxins, hematopoietic stem cell transplantation, hematopoietic growth factors, and immunotherapy. Problems of central-nervous-system therapy, minimal residual disease, drug resistance, and directions of future research are also considered. Discussion of each major topic by two distinguished groups of investigators ensures broad and balanced coverage.
Comprehensive and up-to-date, Treatment of Acute Leukemias: New Directions for Clinical Research offers oncologists practical guidelines for precise diagnosis and optimal treatment of childhood and adult acute leukemia, as well as insights into those aspects of patient management most in need of further study and refinement.

Reviews

"...This book offers the best approach to the presentation of problems related to the treatment of the acute leukemias that I know of. The idea of having different groups of investigators give their views on the topics and the emphasis on future directions make it an important contribution to the study of leukemia. Treatment of Acute Leukemias should be read by both adult and pediatric hematologists and oncologists, and it should be required reading for trainees in these disciplines. Dr. Pui, who has already made major contributions through his own work, has added greatly to the future of the field by organizing and editing this impressive book." -New England Journal of Medicine

"...comprehensive and up to date. This is one of the best books produced in recent years on the diagnosis and management of the acute leukaemias." - European Journal of Haematology

Editors and Affiliations

  • St. Jude Children’s Research Hospital, University of Tennessee Health Science Center, Memphis, USA

    Ching-Hon Pui

Bibliographic Information

  • Book Title: Treatment of Acute Leukemias

  • Book Subtitle: New Directions for Clinical Research

  • Editors: Ching-Hon Pui

  • Series Title: Current Clinical Oncology

  • DOI: https://doi.org/10.1007/978-1-59259-307-1

  • Publisher: Humana Totowa, NJ

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 2003

  • Hardcover ISBN: 978-0-89603-834-9Published: 14 November 2002

  • Softcover ISBN: 978-1-61737-212-4Published: 19 November 2010

  • eBook ISBN: 978-1-59259-307-1Published: 14 November 2002

  • Series ISSN: 2364-1134

  • Series E-ISSN: 2364-1142

  • Edition Number: 1

  • Number of Pages: XVI, 562

  • Topics: Hematology

Publish with us